ICVX
Price
$10.50
Change
+$0.38 (+3.75%)
Updated
Dec 1, 6:59 PM EST
115 days until earnings call
RNA
Price
$8.10
Change
+$0.29 (+3.71%)
Updated
Dec 1, 6:59 PM EST
85 days until earnings call
Ad is loading...

Compare predictions ICVX vs RNA

Header iconICVX vs RNA Comparison
Open Charts ICVX vs RNABanner chart's image
Icosavax
Price$10.50
Change+$0.38 (+3.75%)
Volume$375.83K
CapitalizationN/A
Avidity Biosciences
Price$8.10
Change+$0.29 (+3.71%)
Volume$1.05M
CapitalizationN/A
View a ticker or compare two or three
ICVX vs RNA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ICVX vs. RNA commentary
Dec 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICVX is a StrongBuy and RNA is a Buy.

COMPARISON
Comparison
Dec 04, 2023
Stock price -- (ICVX: $10.50 vs. RNA: $8.10)
Brand notoriety: ICVX and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICVX: 183% vs. RNA: 153%
Market capitalization -- ICVX: $557.51M vs. RNA: $456.46M
ICVX [@Biotechnology] is valued at $557.51M. RNA’s [@Biotechnology] market capitalization is $456.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICVX’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • ICVX’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than ICVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICVX’s TA Score shows that 6 TA indicator(s) are bullish while RNA’s TA Score has 6 bullish TA indicator(s).

  • ICVX’s TA Score: 6 bullish, 4 bearish.
  • RNA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ICVX and RNA are a good buy in the short-term.

Price Growth

ICVX (@Biotechnology) experienced а -4.63% price change this week, while RNA (@Biotechnology) price change was +29.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

ICVX is expected to report earnings on Mar 28, 2024.

RNA is expected to report earnings on Feb 27, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ICVX with price predictions.
OPEN
A.I.dvisor published
a Summary for RNA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ICVX($558M) has a higher market cap than RNA($456M). ICVX YTD gains are higher at: 32.242 vs. RNA (-63.497). ICVX has higher annual earnings (EBITDA): -103.19M vs. RNA (-215.3M). RNA has more cash in the bank: 543M vs. ICVX (229M). ICVX has less debt than RNA: ICVX (8.07M) vs RNA (10.6M). RNA has higher revenues than ICVX: RNA (10.1M) vs ICVX (0).
ICVXRNAICVX / RNA
Capitalization558M456M122%
EBITDA-103.19M-215.3M48%
Gain YTD32.242-63.497-51%
P/E Ratio27.78N/A-
Revenue010.1M-
Total Cash229M543M42%
Total Debt8.07M10.6M76%
TECHNICAL ANALYSIS
Technical Analysis
ICVXRNA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SKGIX17.560.39
+2.27%
Steward Small Cap Growth I
MFCIX35.820.54
+1.53%
Meridian Contrarian Investor
PHSZX44.360.60
+1.37%
PGIM Jennison Health Sciences Z
LMUSX19.160.15
+0.79%
Franklin U.S. Large Cap Equity FI
FZEMX35.010.09
+0.26%
Fidelity Advisor® Emerging Markets Z

ICVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICVX has been loosely correlated with MEIP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ICVX jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICVX
1D Price
Change %
ICVX100%
+3.75%
MEIP - ICVX
51%
Loosely correlated
+0.98%
RNA - ICVX
49%
Loosely correlated
+3.71%
DYN - ICVX
38%
Loosely correlated
+1.08%
KYMR - ICVX
36%
Loosely correlated
+0.05%
CABA - ICVX
32%
Poorly correlated
+15.42%
More